Notably, our findings indicate that p53 expression can be used to identify a p53+ luminal A-like breast cancer phenotype that is characterized by younger age at onset, high KI67 proliferation index, high EGFR expression, as well as associations with parity and breastfeeding practices. Here, EGFR is linked to breast carcinoma.